Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans

Autor: Jakob Benedict Seidelin, Jens Vilstrup Johansen, Marina Ramírez Galera, Lene Riis, Tine Rask Licht, Benjamin E. Mead, Anders Woetmann, Martin Iain Bahl, Jeffrey M. Karp, Jacob Tveiten Bjerrum
Rok vydání: 2021
Předmět:
Male
0301 basic medicine
DAMP
damage-associated molecular pattern

ILC3
RC799-869
Flare Initiation
0302 clinical medicine
AMP
antimicrobial peptide

Intestinal Mucosa
Original Research
IBD
inflammatory bowel disease

Gastroenterology
Sigmoid colon
ILC
innate lymphoid cell

Middle Aged
Diseases of the digestive system. Gastroenterology
Control subjects
Immunohistochemistry
Ulcerative colitis
rRNA
ribosomal RNA

medicine.anatomical_structure
MES
Mayo endoscopic subscore

Disease Progression
Innate Lymphoid Cells Type 3
qPCR
quantitative polymerase chain reaction

Cytokines
Female
030211 gastroenterology & hepatology
Disease Susceptibility
Injury model
Inflammation Mediators
medicine.symptom
Acute Mucosal Injury
PAMP
pathogen-associated molecular pattern

Adult
Innate Intestinal Response
Inflammation
03 medical and health sciences
GO
Gene Ontology

CD
Crohn’s disease

medicine
Humans
Ulcerative Colitis
Microbiome
Aged
Host Microbial Interactions
Hepatology
business.industry
Endoscopy
NCR
natural cytotoxicity receptor

medicine.disease
Immunity
Innate

Lymphocyte Subsets
IL
interleukin

Gastrointestinal Microbiome
UC
ulcerative colitis

030104 developmental biology
Case-Control Studies
Immunology
Dysbiosis
Colitis
Ulcerative

business
Biomarkers
Zdroj: Seidelin, J B, Bahl, M I, Licht, T R, Mead, B E, Karp, J M, Johansen, J V, Riis, L B, Galera, M R, Woetmann, A & Bjerrum, J T 2021, ' Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans ', Cellular and Molecular Gastroenterology and Hepatology, vol. 12, no. 4, pp. 1281-1296 . https://doi.org/10.1016/j.jcmgh.2021.06.002
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 4, Pp 1281-1296 (2021)
Cellular and Molecular Gastroenterology and Hepatology
ISSN: 2352-345X
DOI: 10.1016/j.jcmgh.2021.06.002
Popis: Background and aims The trigger hypothesis opens the possibility of anti-flare initiation therapies by stating that ulcerative colitis (UC) flares originate from inadequate responses to acute mucosal injuries. However, experimental evidence is restricted by a limited use of suitable human models. We thus aimed to investigate the acute mucosal barrier injury responses in humans with and without UC using an experimental injury model. Methods A standardized mucosal break was inflicted in the sigmoid colon of 19 patients with UC in endoscopic and histological remission and 20 control subjects. Postinjury responses were assessed repeatedly by high-resolution imaging and sampling to perform Geboes scoring, RNA sequencing, and injury niche microbiota 16S ribosomal RNA gene sequencing. Results UC patients had more severe endoscopic postinjury inflammation than did control subjects (P < .01), an elevated modified Geboes score (P < .05), a rapid induction of innate response gene sets (P < .05) and antimicrobial peptides (P < .01), and engagement of neutrophils (P < .01). Innate lymphoid cell type 3 (ILC3) markers were increased preinjury (P < .01), and ILC3 activating cytokines were highly induced postinjury, resulting in an increase in ILC3-type cytokine interleukin-17A. Across groups, the postinjury mucosal microbiome had higher bacterial load (P < .0001) and lower α-diversity (P < .05). Conclusions UC patients in remission respond to mucosal breaks by an innate hyperresponse engaging resident regulatory ILC3s and a subsequent adaptive activation. The postinjury inflammatory bowel disease–like microbiota diversity decrease is irrespective of diagnosis, suggesting that the dysbiosis is secondary to host injury responses. We provide a model for the study of flare initiation in the search for antitrigger-directed therapies.
Graphical abstract
Databáze: OpenAIRE